FyoniBio SA provides services for biologics development, bioanalytical characterization and clinical trial laboratory support. Its service portfolio includes cell-line development, process development, mass spectrometry analytics, clinical bioanalysis and functional/potency bioassays, and its laboratories follow GCLP standards with ISO 9001:2015 certification.
AI-generated
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Full suite of biologics development services, integrated workflows or standalone solutions from concept to scalable manufacturing, including cell line development, process optimization and bioanalytics.
Cell Line Development
Mammalian cell line development for biotherapeutics, including CHO and human expression systems, host cell line feasibility studies, and platform-based development with CHOnamite®, CHOFlow® and GlycoExpress®.
Process Development
Integrated upstream and downstream process development, including batch, fed-batch, intensified fed-batch and perfusion modes, purification, formulation development, stability studies and tech transfer support.
Bioanalytical Characterization
Bioanalytical characterization of biologics across development stages, including biochemical analytics, mass spectrometry, functional and potency assessments, comparability studies and regulatory-ready documentation.
Mass Spectrometry Analytics
Mass spectrometry-based characterization of biotherapeutics, including intact mass, glycan profiling, glycopeptides, peptide mapping, PTM analysis and antibody-drug conjugate DAR assessment.
Knowledge
No knowledge articles yet
Once FyoniBio SA has claimed this profile, we'll publish editorial articles and case studies here together.